Ecological momentary assessment (EMA) is gaining importance in psychiatry. This article assesses the characteristics of patients who used a new electronic EMA tool: the MEmind Wellness Tracker. Over one year, 13811 adult outpatients in our Psychiatry Department were asked to use MEmind. We collected information about socio-demographic data, psychiatric diagnoses, illness severity, stressful life events and suicidal thoughts/behavior. We compared active users (N = 2838) and non-active users (N = 10,973) of MEmind and performed a Random Forest analysis to assess which variables could predict its use. Univariate analyses revealed that MEmind-users were younger (42.2 ± 13.5 years versus 48.5 ± 16.3 years; χ 2 = 18.85; P < 0.001) and more frequently diagnosed with anxiety related disorders (57.9% versus 46.7%; χ 2 = 105.92; P = 0.000) than non-active users. They were more likely to report thoughts about death and suicide (up to 24% of active users expressed wish for death) and had experienced more stressful life events than non-active users (57% versus 48.5%; χ 2 = 64.65; P < 0.001).
| INTRODUCTION
Three out of four persons in Western societies use the internet regularly (Internet World Stats, 2015) . According to the European Survey on Information and Communication Technology, in 2013, 72% of Europeans used the internet at least once a week and 62% of them used it every day or almost every day. The proportion of individuals who have never used the internet decreased from 42% in 2006 to 21% in 2013 (Eurostat, 2013) . In Spain, figures are similar. In 2014, 71.2% of individuals aged between 16 and 74 years used the internet at least once a week and 60% used it daily (Instituto Nacional de Estadistica, 2014) Given its widespread use, it is not surprising that the internet has reached the health sector, and currently electronic health (e-Health) is an expanding field. Electronic mental health (e-Mental Health) is an emergent area within e-Health (Firth, Torous, & Yung, 2016; Marzano et al., 2015) . E-Mental Health delivers or enhances mental health services and information through the internet and related technologies (Christensen & Hickie, 2010; Lal & Adair, 2014; Mental Health Commission of Canada, 2014) . It comprises different instruments such as computerized interventions, virtual reality or gaming in the therapeutic field, telehealth and telemedicine, peer support through social media and other technologies, and evaluation of big data or symptoms by means of web tools, smartphone technologies or wearable devices (Mental Health Commission of Canada, 2014) .
With regards to evaluation, e-Mental Health techniques enable clinical and research approaches that focus on capturing real-world and real-time data, typically referred to as ecological momentary assessment (EMA) (Stone, Shiffman, Atienza, & Nebeling, 2007) . Using EMA, symptoms are captured at the moment they occur or very shortly thereafter, thus reducing retrospective recall biases associated with traditional medical visits. EMA also allows self-assessment in natural environments, rather than institutional settings, thus maximizing ecological validity (Shiffman, Stone, & Hufford, 2008) .
Regarding the validity of online health interviews, evidence supports that people are more forthright on online health questionnaires than during face-to-face interviews (Bennett & Glasgow, 2009 ), especially regarding sensitive areas of importance in psychiatry, such as traumatic events, substance abuse or suicidal thoughts and/or behavior (Barak, 2007; Christensen & Hickie, 2010; Lin et al., 2007) Since its development, EMA has been used to investigate different psychiatric disorders such as anxiety (Walz, Nauta, & Aan Het Rot, 2014) , obsessive compulsive disorder (Tilley & Rees, 2014) (Forbush & Hunt, 2014; Hilbert & Tuschen-Caffier, 2007; Smyth et al., 2007) , substance use disorders (Shiffman, 2009) , borderline personality disorder (Hasler, Hopwood, Jacob, Brändle, & Schulte-Vels, 2014; Santangelo, Bohus, & Ebner-Priemer, 2012) and, most recently, in population at risk for suicide (Husky et al., 2014) . EMA instruments provide a framework for ecological assessments in psychiatry but to date their application is heterogeneous and not comprehensive; although there have been close correlates in the field of primary care, such as the "My Own Health Report" which assesses 10 domains of health behaviors and psychosocial issues: eating patterns, physical activity, sleep, smoking, risky drinking, substance abuse, stress, anxiety and depression, overall health status and demographics (Glasgow et al., 2014) .
With a substantial growth in its research over the last five years, use of EMA tools has gained broad acceptance in research (Firth et al., 2016) , but there is still a lack of knowledge in clinical practice.
Moreover, some initiatives that tried to introduce e-Health into daily life have failed. For instance, only 0.13% of people invited to HealthSpace, a personal electronic health record promoted by the National Health Service (NHS) in England, opened an advanced account (Greenhalgh, Hinder, Stramer, Bratan, & Russell, 2010) . These facts highlight the need for a proper characterization of those patients who are prone to use e-Health apps.
The aim of this study was to determine the socio-demographic and clinical characteristics of active users of a new EMA tool, MEmind Wellness Tracker. This knowledge may help to step forward the actual shortcomings in the adherence of EMA and e-Mental Health apps. We hypothesize that active MEmind users will present a specific profile indicating a higher vulnerability to anxiety and affective disorders and suicidal behaviors.
| MATERIAL AND METHODS

| Materials: MEmind Wellness Tracker
MEmind is a web application that was developed to merge different data sources (including patient and caregiver inputs) and provide summaries of the patient state in clinical practice. The web application is available at www.memind.net using internet-connected devices including Smartphone, Tablet and computers (with any operating system). The MEmind application has two interfaces, one for clinicians:
the "electronic health record (EHR) view" and another for patients:
the "EMA view" (clinicians can access data registered by patients in subsequent visits and use this information in their treatment routine).
The EHR view was designed to capture data from standard psychiatric assessments, including socio-demographic, diagnostic and treat- Table S1 ).
All patients in follow-up were eligible for the study. During this first year of use of MEmind, 34,236 patients were assisted in the mental health centers. Inclusion criteria were either male or female outpatients, aged 18 or older, who gave written informed consent. Exclusion criteria were illiteracy, refusal to participate, current imprisonment, being under guardianship and emergency situations in which the patient's state of health did not allow for a written informed consent.
| Ethical considerations and data protection
The study was carried out in compliance with the Declaration of Helsinki and approved by the Local Ethics Committee. All participants gave written informed consent, after a complete description of the study.
Concerning data protection, access to the online user interface was restricted to participating clinicians (MEmind Study Group). User identification was ensured by a username and password. The data provided by the clinician was encrypted by Secure Socket Layer/Transport Layer Security (SSL/TLS) between the investigator's computer and the server. Data was stored in an external server created for research purposes. Only the principal investigator (EBG) had an access code to the server. MEmind used keys when creating encrypted volumes and any snapshots created from the encrypted volumes. Each volume was encrypted with a unique 256-bit key; any snapshots of this volume and any subsequent volumes created from those snapshots also shared that key. These keys were protected by a key management infrastructure, which implemented strong logical and physical security controls to prevent unauthorized access. Data and associated keys were encrypted using the industry-standard AES-256 algorithm. Furthermore, an external auditor guaranteed that security measures met the Organic Law for Data Protection standards at a high protection level.
| Study procedure
Participants were registered in the web tool and received a username and a password. The username remained the same throughout all contacts with psychiatric services within the study area. In this way, any clinician involved in the follow-up of a patient could access his/her MEmind records. Clinicians collected the following information in the EHR: socio-demographic data, ICD-10 (International Classification of Diseases, 10th revision) mental disorder diagnoses (WHO, 1992) , illness severity measured by the Clinical Global Impression (CGI) scale (Guy, 1976) , medical conditions, stressful life events during the previous six months using the Life Threatening Events (LTE) (Brugha & Cragg, 1990 ) and suicidal thoughts and behavior: wish for death, desire for self-harm, thoughts about suicide, suicide plans and suicide attempts.
Subsequently, patients were encouraged to connect to the EMA interface as many times as they wanted to (they were told that they could access the website as often as they wanted and a maximum of one register per day would be created, but no instruction about the frequency of connection was made, similarly no reminder [e.g. e-mail or sms] was made in this first step of MEmind development). Patients who had accessed the web tool at least once were considered active users; otherwise, they were considered non-active users.
| Statistical analysis
Characteristics of active and non-active users were compared using chi-square test and t-test as appropriate. The Statistical Package for the Social Sciences (SPSS) version 22.0 was used for the analyses.
To determine which variables would predict the use of MEmind, we performed feature selection using Random Forest (Breiman, 2001 ) and a 10-fold Cross Validation (CV) approach for model evaluation. Random Forest is a classification algorithm (Breiman, 2001 ) that uses an ensemble of classification trees (Breiman, Friedman, Stone, & Olshen, 1984; Hastie, Tibshirani, & Friedman, 2009; Ripley, 2007) .
Each of the classification trees is built using a bootstrap sample of the data, and at each split the candidate set of variables is a random subset of the variables. Random Forest has demonstrated excellent performance in classification tasks, being comparable to that of support vector machines. It allows selection taking into account possible interactions between variables (Baca- García et al., 2006; Baca-García et al., 2007; Dudoit & Fridlyand, 2003; Liaw & Wiener, 2002; Wu et al., 2003) . In our study, we performed a 10-fold CV approach to avoid model overfitting. We randomly divided the original database into 10 databases. Nine of these folds were used as training sets to estimate the best Random Forest "mtry" and "ntree" parameters (those that confer the lower out-of-bag (OOB) error model) (Breiman, 2001 ).
Using the Random Forest algorithm with these parameters in the remaining fold denominated "test set" (different for each of the 10 databases), the "mean decrease accuracy" (MDA) was calculated for each variable. The MDA is a measure of the impact of each feature on the accuracy of the model (Breiman, 2001) . We selected those variables or features with a mean MDA value higher than zero (mean of 10 estimations in the 10 test sets of the approach for each variable).
Finally, we repeated the same approach (10-fold CV) with the selected variables, to perform a final model evaluation consisting in the estimation of the mean values of accuracy, precision, sensitivity and specificity of the model in the test sets of the 10 databases created.
| RESULTS
From May 2014 to May 2015, 15,438 patients were registered for MEmind, for 1627 patients there were missing data, thus 13,811 patients were analyzed, of which 2838 (20.5%) accessed the EMA interface on at least one occasion. Tables 2 and 3 show the profile of patients regarding suicidal thoughts and behaviors and experience of stressful life events, respectively. Active users were more likely to have thoughts about death and suicide, and up to 24% of them expressed a wish to die (Table 2) . Active users were more likely to experience stressful life events than non-active users, with 57% of active users suffering at least one stressful life event compared to 48.5% of nonactive users (χ 2 = 64.65; P < 0.001) ( Table 3) . 
| Univariate analysis
| Random Forest analysis
| DISCUSSION
Compared to non-active users, patients using MEmind were younger, were more often diagnosed with anxiety or mood disorders but less frequently with psychotic disorders, and had a higher prevalence of wish for death and suicidal ideation. 
| Socio-demographic characteristics
| Use of MEmind according to clinical characteristics
The Random Forest analysis showed that anxiety related disorder and mood disorder diagnoses were among the most important variables predicting to be an active user. Severity of illness was among the top 10 variables predicting to be an active user, with people with less severe illness using MEmind more than those with more severe illness, although this difference was not statistically significant in univariate analysis. This is in line with the promising results obtained by online psychological interventions in mild to moderate depression and anxiety disorders (Cunningham et al., 2014) . Moreover, the current NICE 
| MEmind and self-injurious thoughts and behavior
In our sample, those patients answering affirmatively to questions regarding suicide in clinical evaluation were most likely to be active users. A recent study which used EMA technology for assessing people at different levels of risk for suicide, with daily assessments during one week, found good acceptability among participants. More importantly, negative and suicidal thoughts were not reactivated during repeated assessment (Husky et al., 2014) . These results are consistent with our findings. Patients with suicidal thoughts tended to use MEmind, probably because they felt comfortable with the anonymous nature of the online interface (Barak, 2007; Christensen & Hickie, 2010; Lin et al., 2007) . In light of these results it seems plausible to consider that an adequate identification of these subjects at risk could help in the development of specific preventive and/or clinical interventions.
As a related issue, it is worth mentioning a pioneer study seeking to evaluate suicidal behavior using the internet with a large -more than 48,000 people -population-based sample (de Araújo, Mazzochi, Lara, & Ottoni, 2015) . Speaking of this project, Grunebaum stated that "Big Data has reached the field of suicidology" (Grunebaum, 2015) , thus highlighting the growing importance of EMA methodology in investigation of the suicide phenomenon. Another interesting project using the internet is the Israeli-based suicide-prevention initiative, SAHAR (Barak, 2007) . Although in our pilot analysis we did not initially consider developing prevention strategies for those subjects reporting self-injurious thoughts and behaviors, given the results of our study we believe that the development of a preventive protocol would be a feasible goal in the future. The main strength of our study is the development of a powerful novel tool for efficient data collection from a very large sample.
MEmind is an EMA tool designed for the comprehensive evaluation of mental conditions, with easy access through any device with internet connection (a mobile app will soon be available). Not only does our web tool have important implications for research in mental health, but also promises to be an effective aid in clinical practice.
Furthermore, MEmind provides patients a space where they can freely express themselves. It is well known that this sense of privacy can facilitate sincerity concerning more sensitive questions (Barak, 2007; Christensen & Hickie, 2010; Lin et al., 2007) . In this study we did not analyze the comments of active users, but we observed that a larger proportion of those answering affirmatively to questions regarding suicide asked by the clinician were active users, probably in relation with this sense of security and privacy.
Unlike other studies, our participants were not instructed about a desired frequency of use of the tool and no reminder was made in order to avoid the inconvenience associated with EMA research designs and to minimize the risk of intrusiveness into daily life (Rhee, Miner, Sterling, Halterman, & Fairbanks, 2014).
Our study has also some limitations. First of all, only a small percentage -around 20% -of recruited participants decided to use MEmind, which challenges us to develop strategies to engage patients with our tool. Secondly, at present our tool is designed for evaluation with no option for treatment, a possibility that would be particularly important with regards to suicide, as we have observed people with wish for death and suicidal ideation are willing to use the web tool. A future addition will be a warning message for the clinician when a patient repeatedly provides affirmative information about suicidal ideation. Finally, there are limitations inherent to the use of MEmind in the clinical setting as it is relatively time-consuming for clinicians during consultation, which complicates optimal data collection.
Most importantly, taking into account our results and as mentioned earlier, our web tool has many future possibilities. As one of the current limitations is the low rate use, gamification (the implementation of mechanics of video games in non-video game contexts) could be an interesting strategy (Miller, Cafazzo, & Seto, 2014) . In addition, personalized questionnaires, giving feedback and permitting patient access to their own registers and symptom charts could promote usability. We have developed an interface for family and caregivers in order to add information, which is particularly useful in child patients and those with severe mental illness. As a final goal, intervention and treatment modules will be developed, which will make MEmind a more interpreting the data, writing, and publishing the report.
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